Page 168 - CW E-Magazine (19-3-2024)
P. 168

News from Abroad


       TOUGH TIMES
       DSM-Firmenich completes divestiture of vitamin C

       plant in China


          DSM-Firmenich has announced  pany had decided to accelerate a series  specialty Quali-C from Dalry, UK only.
       the successful sale and transfer of its  of actions to restructure its vitamin  The production of vitamin C in Jiang-
       100% equity interest in DSM Jiangshan  business, in a bid to lessen its exposure  shan,  which  had  already  been  signifi-
       Pharmaceutical  Co., Ltd. to Jingjiang  to market and earnings volatility.  cantly reduced since the end of 2022,
       Cosfocus Health Technology Co., Ltd.                               was completely shut down in mid-May
       Financial details of the transaction were   One  key  part of  the strategy was  2023.
       not disclosed.                    restructuring of the vitamin asset foot-
                                         print to reduce costs.  This included   The company had said that it is ex-
          In June last year, in response to fur-  the closure of the Xinghuo vitamin B6  ploring a range of options for the Jiang-
       ther weaking of the vitamins market   plant in China and the refocusing of the  shan site including partnerships or the
       affecting pricing and volumes, the com-  company’s vitamin  C activities  on its  repurposing of the manufacturing assets.

       Univar and Arxada announce biocide distribution

       partnership for Brazil


          US-based distribution firm, Uni-  formance additives tailored to preser-  chemistries and launching innovative
       var’s Brazilian arm, Univar Solu-  vation and microbial control.   products that prioritise sustainability
       tions Brasil Ltda., has announced                                  while remaining high performing,”
       a new distribution agreement with   “We are delighted  to announce  said Mr. Matthew Oliver, Global Vice
       Swiss speciality chemicals firm,  our partnership with Arxada in indus-  President of Performance Materials
       Arxada, for a full range of biocides,  trial  paints and coatings markets and  for Univar Solutions. “Working with
       preservatives, and performance addi-  the lubricants space, focusing jointly  speciality ingredient suppliers like
       tives used  in  a variety of industrial  on  sustainability  without  sacrificing  Arxada, we  can offer customers the
       applications.                     performance  for our customers,” said  latest guidance, bio-based materials,
                                         Mr. Jorge Buckup, President of Latin  and solutions such as corrosion inhi-
          The new agreement  strengthens  America for Univar Solutions.   bitors, antimicrobials, lubricants,  and
       Univar’ product offerings in Brazil’s                              other specialty additives to provide
       paints,  coatings, and lubricants  mar-  “We are committed to supporting  efficacy in coating systems and mate-
       kets by adding antimicrobials and per-  manufacturers who are reformulating  rial protection,” he added.

       Shin-Etsu Chemical to double capacity for hypromellose

       acetate succinate


          Japan’s Shin-Etsu Chemical has  pient  hypromellose  acetate  succinate  used, for example as tablet coating
       announced plans to make investments  (marketed under the name  AQOAT)  agents due to their recognition as being
       to strengthen the pharmaceutical cellu-  with a completion time of Q2, 2026.  safe for the human body.  AQOAT,
       lose business. These investments will  The estimated investment is Yen 10-bn  which is used in enteric drugs to con-
       be implemented in the Naoetsu plant  (around $68-mn).              trol the drug delivery target in the
       (Joetsu city, Niigata Prefecture).                                 human body, is a patented invention
                                           Shin-Etsu Chemical’s  pharmaceu-  by Shin-Etsu Chemical as an enteric
           The plan is to double the manufac-  tical excipients are made mainly from  coating agent and is supplied all over
       turing capacity of pharmaceutical exci-  plant-derived pulp and are widely   the world.


       168                                                                    Chemical Weekly  March 19, 2024


                                      Contents    Index to Advertisers    Index to Products Advertised
   163   164   165   166   167   168   169   170   171   172   173